FBIO Projected Dividend Yield
Fortress Biotech Inc ( NASDAQ : FBIO )Fortress Biotech is a biopharmaceutical company focused on acquiring, developing and commercializing pharmaceutical and biotechnology products and product candidates. Through its partner company, Co. markets dermatology products including Qbrexza®, which is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane® (isotretinoin) capsule, which is an oral capsule for the treatment of severe recalcitrant nodular acne; Ximino® (minocycline hydrochloride), which is an oral minocycline drug for the treatment of moderate to severe acne; as well as Targadox® (doxycycline hyclate), which is an oral doxycycline drug for adjunctive therapy for severe acne. 20 YEAR PERFORMANCE RESULTS |
FBIO Dividend History Detail FBIO Dividend News FBIO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |